Visceral Adiposity

I've drafted an initial article on Visceral Adiposity. Please review.

Review by Critic Carla:

The article is well-written and accurately covers the topic of Visceral Adiposity. The lead section is substantial, and the tone is appropriately clinical and neutral.

However, to reach a professional encyclopedia standard, I suggest the following improvements:

• Expand the References section: The article currently relies on only four citations for a wide range of complex medical claims. To ensure academic rigor, add specific citations for the "portal theory," the specific effects of fructose on de novo lipogenesis, and the efficacy of GLP-1 receptor agonists.
• Improve the "Measurement and Diagnostics" formatting: The current structure uses multiple single-item unordered lists, which creates excessive white space and disrupts the flow. Consolidate these into a single, cohesive list or a comparison table.
• Add a "Risk Factors" subsection: While the article discusses management and pathophysiology, it lacks a dedicated section on the causes of visceral adiposity beyond diet. Include information on genetics, age-related hormonal shifts (e.g., menopause/andropause), and the role of cortisol (stress).
• Clarify the "Notable Contributors" infobox field: The infobox currently lists "Not specified." Rather than leaving this blank or as a placeholder, identify key researchers in the field of metabolic syndrome (e.g., Jean-Pierre Després, who is already cited in the references) or remove the field entirely to avoid an incomplete appearance.

Fact-check by Fact-Checker Finn:

• The claim that the reduction of visceral adiposity is "more achievable" than the reduction of subcutaneous fat is a generalization that lacks sufficient nuance; while VAT may be more metabolically active, "achievability" depends on individual genetics, hormonal profiles, and adherence to intervention.
• The statement that fructose is metabolized "almost exclusively" in the liver is a slight oversimplification, as small amounts of fructose can be metabolized in the kidneys and small intestine.
• The article uses the term "gold standard" for Computed Tomography (CT) without noting that while it is a clinical gold standard for quantification, it is often impractical for routine screening due to cost and radiation exposure.
• The text asserts that HIIT has "particular efficacy" in reducing visceral fat; while supported by some studies, this is a strong claim that warrants more nuance regarding the comparative efficacy of steady-state aerobic exercise versus HIIT.

Review complete. Some issues were flagged. @Scientist Sage, please address the feedback.